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Statistics from the Northern Ireland Drug Misuse Database:  
1 April 2001 – 31 March 2002 
 
This bulletin summarises information on people presenting to services with problem drug 
misuse and relates to the 12-month period ending 31 March 2002. It is the first bulletin 
reporting on information collected through the Northern Ireland Drug Misuse Database 
(DMD), which was established in April 2000 and which collects detailed data, including 
information on drugs misused and injecting behaviour,  on those presenting for treatment. 
  
Summary 
 
In Northern Ireland during the twelve month period 
ending 31 March 2002: 
 
• Information relating to 969 individuals presenting to 
drug misuse agencies was received: in 916 cases 
(95%) client consent was given for including data 
within the DMD. 
• Almost three-quarters of users presenting were male; 
just over two-fifths of users were in their twenties, 
whilst more than a fifth were aged under 20. 
• Cannabis was recorded as the main drug of misuse for 
around one-third (34%) of users, the next most 
common main drug of misuse being heroin (21%). 
This contrasts with Great Britain where typically 
around two-thirds of those presenting record heroin as 
their main drug of misuse. Other opiates were 
recorded as main drug for 14% of users and ecstasy 
for 9%.  
• 74% of those presenting for treatment with heroin as 
the main problem drug had been treated before; the 
figures for cannabis and ecstasy were much lower 
(23% and 21% respectively).  
• The majority (74%) of users reported never having 
injected a drug: only a quarter of users have injected 
of the 861 users whose injecting history is known. 
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1.  Introduction  
1.1 In 1995, the Northern Ireland Drugs 
Policy Statement highlighted the need for a 
centralised database on drug misuse in 
Northern Ireland. The then Department of 
Health and Social Services (DHSS) 
subsequently commissioned a feasibility 
study that considered the experience 
elsewhere (databases already existed in 
Scotland, Wales, and regionally in 
England), data availability, and data quality 
in Northern Ireland and took due account of 
issues of confidentiality. The study found 
that the majority of agencies were 
supportive of the idea of a drug misuse 
database and identified a number as 
potential providers. 
 
1.2 Subsequently the Northern Ireland 
Drug Misuse Database (DMD) was 
established and data collection commenced 
from April 2000 – more details of the DMD 
are contained in Annex C.  The database is 
maintained by the Drug and Alcohol 
Information and Research Unit (DAIRU) 
located within the Department of Heath, 
Social Services, and Public Safety 
(DHSSPS).  This bulletin is the first to be 
published using data from the DMD and 
covers the period 1 April 2001 – 31 March 
2002. By the end of 2001-2002, 23 
treatment sites were contributing to the 
database of which 10 were non-statutory  
and 13 were statutory.   
 
1.3 The DMD collects information on 
problem drug users presenting to services 
for the first time, or for the first time in six 
months or more. A problem drug user is 
defined as a person who experiences social, 
psychological, physical or legal problems 
(related to intoxication and/or regular 
excessive consumption and/or dependence) 
as a consequence of their own use of drugs 
or chemical substances. Drugs are defined 
as any drug, whether prescribed or not, 
including solvents and tranquillisers but 
excluding alcohol and tobacco. The data are 
collected from drug treatment agencies and 
include selected personal details and 
information regarding the drugs misused 
and the type of agency attended: these data 
are passed on in anonymised form to 
DAIRU for incorporation in the DMD. As 
client participation in the DMD is voluntary, 
in a number of instances consent was 
withheld and full information relating to 
these clients has not been incorporated into 
the DMD. (see Table 1: all main tables are 
contained in Annex A) 
 
Northern Ireland Executive’s Drug 
Strategy 
1.4 The current Northern Ireland Drug 
Strategy was developed pre-devolution to be 
consistent with the UK Government’s 
Strategy introduced in 1998 (“Tackling 
Drugs to Build a Better Britain”). The 
Northern Ireland Strategy placed a clear 
emphasis on the need for good information 
to support drug policy and practice, and 
identified a drug misuse database as one 
approach to collecting information.  In May 
2001 the Northern Ireland Executive 
endorsed a model for the joint 
implementation of the Drug Strategy and the 
Strategy for Reducing Alcohol Related 
Harm. Under this model, a number of new 
working groups, including the Information 
and Research Working Group (IRWG), 
were established. The DMD is an important 
strand of the programme of work to be taken 
forward by this group and by DAIRU in 
support of the two strategies.    
 
1.5 The aim of the DMD is to provide 
high-quality, consistent information on the 
numbers and profiles of presenting problem 
drug users to inform both policy and 
practice. The database will be kept under 
review. 
 
Other Information Available 
1.6 It is important to note that the report 
does not provide information on the overall 
size and nature of the problem of drug use 
or misuse in Northern Ireland. A number of 
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other strands of research instigated by the 
Information and Research Working Group 
complement this DMD publication. In June 
2002, a study into the extent of problem 
heroin use in Northern Ireland was 
published; in October 2002, a secondary 
analysis of survey data relating to drugs and 
drug use amongst young people was 
published; and in August 2002, an all-island 
drug prevalence survey was commissioned 
jointly with the National Advisory 
Committee on Drugs in the Republic of 
Ireland. Details of these and other research 
projects are given in Annex D. 
 
Participation in the DMD 
1.7 Client participation in the DMD is 
optional and depends on client consent. 
Information was received from 969 
individuals presenting for treatment, and 
client consent was withheld in 53 (5%) of 
cases (Table 1). All figures in this report are 
based on the 916 individuals who gave their 
consent for their information to be 
incorporated in the DMD. 
2. Profile of service users 
 
Age and Gender of Users 
2.1 Males accounted for almost three-
quarters of those presenting to services in 
2001-2 (Table 2). This gender ratio of 
around three males to one female is similar 
to the typical distribution found in GB over 
recent years. GB figures have been 
published in a series of statistical bulletins 
by the Department of Health  (for example 
see Bulletin 2002/7 “Statistics from the 
Regional Drug Misuse Databases for six 
months ending March 2001”).  
 
2.2 The mean age of those presenting for 
treatment was 27, with over two-fifths of 
users being in their twenties. Just over one 
fifth (22%) of those presenting for treatment 
were aged under twenty, whilst only 11% 
were aged 40 or over (Table 3).  
 
2.3 The age profile for females was 
slightly older than that for males: 34% of 
men were aged 30 or more, whilst the 
corresponding figure for women was 44%. 
(Table 4; Figure 1) 
 
Geography 
2.4 Just over half (51%) of users 
presented for treatment in the Eastern 
Health and Social Services Board area, 
whilst only 4% were being treated in the 
Southern HSSB area (Table 2). It should be 
noted that these figures are based on where 
people presented for treatment, not their 
place of residence. Data on place of 
residence for those registered on the DMD 
are incomplete, as only 5-figure postcodes 
are available, and, in some instances, 
postcode data are missing or erroneous. For 
people whose area of residence could be 
determined, 91% lived in the same HSSB 
area as they were treated in. This suggests 
that HSSB of treatment is a reasonable 
proxy for HSSB of residence. The exception 
is the Southern HSSB area where only one 
third of users residing in the area were 
treated there.  
 
2.5 The incidence of treatment per 
100,000 population was higher in the 
Western and Eastern HSSB areas (90 and 79 
per 100,000 population respectively) than in 
the Northern (37 per 100,000 population) 
Figure 1. Age and gender of individuals 
presenting for treatment: 2001-2002
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and especially the Southern (11 per 100,000 
population). (Figure 2) 
 
2.6 This picture reflects the position for 
those agencies contributing to the DMD; as 
coverage of the DMD expands (see Annex 
C), the picture will become more definitive.  
 
Type of Treatment Service Agency 
2.7 Most users (69%) presented for 
treatment at statutory agencies. The picture 
varied sharply across Northern Ireland, with 
more than half (52%) of users in the Eastern 
HSSB area presenting to non-statutory 
agencies, whilst in the Northern Board all 
users presented to statutory agencies; the 
use of non-statutory agencies in the 
Southern and Western HSSBs was also 
limited. Again, as more treatment agencies 
contribute to the DMD this position will 
become clearer. (Table 5) 
 
 
3. Drugs of Misuse 
 
Background 
3.1 Users must record at least one drug 
of misuse in order to be entered on the 
DMD – this is listed as the main drug of 
misuse; they can be recorded as misusing a 
maximum of four other drugs. Figure 3 
shows that just over two-fifths of users were 
recorded as misusing only one drug; just 
over one fifth misused two drugs; and 
smaller proportions misused three, four, and 
five drugs. An unknown proportion of those 
users recorded as misusing five drugs would 
have been misusing more than this, but only 
five drugs are recorded on the DMD. Most 
of the figures in this bulletin are based on 
the main drug of misuse, although some 
analyses report on all drugs of misuse.  
 
Figure 3: Number of drugs misused per 
user: 2001-2002
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Main Drug of Misuse 
3.2 Cannabis was the most frequently 
reported main drug of misuse, accounting 
for around one third (34%) of those 
presenting for treatment. Heroin was 
reported by 21% of users; other opiates by 
14%; and ecstasy by 9%. The “other 
opiates” group includes drugs such as 
codeine, nubain, and morphine but excludes 
heroin and methadone, which are listed 
separately. These figures are considerably 
different from those in GB, which show that 
typically around two-thirds of users report 
heroin as their main drug of misuse. (Figure 
4, Table 6) 
 
3.3 There was considerable variation 
between males and females in main problem 
drugs used. Nearly two-fifths (39%) of 
males reported cannabis as their main drug 
of misuse, almost double the proportion of 
females (20%). Heroin misuse amongst 
males (24%) was also higher than the 
Figure 2. Rates per 100,000 population 
presenting for treatment in Health and 
Social Services Board Areas: 2001-2002
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corresponding figure for females (14%). 
Other opiates, on the other hand, were much 
more likely to be the main drug for females, 
accounting for between one quarter and one 
third (30%) of all women presenting for 
treatment, but only 8% of men. (Table 6) 
 
3.4 There were also differences by age: 
solvents were common only amongst young 
people aged 15 or less – solvents accounted 
for 48% of users in this age group: cannabis 
for almost all of the rest. 16-19 year olds 
were much more likely to present for 
cannabis (54%) than any other drug. In 
general, users aged between 20 and 39 were 
as likely to present for heroin as for 
cannabis, whilst for those aged over 40, 
other opiates were the main presenting 
drugs (35%), partly accounting for the 
higher proportion of women presenting for 
treatment for problems with other opiates. 
(Table 7)  
 
3.5 The average (mean) age reported for 
first use of the main drug was 20. Nearly 
one third reported using their main drug of 
misuse before the age of 16, whilst a similar 
proportion reported taking it between the 
ages of 16 and 19. Only 12% reported first 
using their main drug at the age of 30 or 
over. (Figure 5) Consideration of these 
figures needs to take account of the fact that 
the age profile of those presenting for 
treatment is young, with only 37% aged 30 
or more. 
 
3.6 There were substantial differences in 
age of first use for different drugs. The 
lowest average age of first use was for 
solvents (nearly 13 years) closely followed 
by amphetamines (age 14). The average age 
Figure 4. Main drugs of misuse: 2001-2002
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of first use of cannabis was 16 and of 
ecstasy, 18. Heroin (21); cocaine (22); and 
crack (22) had similar average ages of first 
use, whilst benzodiazepines (26) and other 
opiates (27) tended to be used for the first 
time at later ages. (Figure 6) 
 
Geography 
3.7  Those presenting for treatment in 
the Northern Board area were much more 
likely to have heroin as their main drug 
(84% of users in this area) than any other 
drug. The percentages reporting heroin as 
their main drug in other Board areas is much 
lower (Eastern, 10%; Southern, 18%; and 
Western, 4%). In other Board areas the main 
presenting drug was cannabis with 42% of 
users in the Western Board area reporting 
this as their main drug: the corresponding 
figures for the Eastern and Southern Board 
were 40% and 35% respectively. The 
percentage from the Northern Board area 
reporting cannabis as their main drug of 
misuse was 3%. (Table 8)  
 
All drugs of misuse    
3.8 Those presenting for treatment may 
be misusing more than one drug, and up to 
four additional drugs of misuse can be 
recorded on the DMD. Some drugs – mostly 
the class A drugs such as heroin and cocaine 
– tend to be recorded as main drugs if they 
are being used at all. As seen in Table 9, 
221 people reported use of heroin, the 
majority of these (196 or 89%) reporting 
heroin as their main problem drug. Other 
drugs showed a greater propensity to be 
recorded as subsidiary drugs – for example 
243 users reported use of ecstasy, but 
ecstasy was the main problem drug in only 
87 (36%) of these instances.  
 
3.9 Table 9, which contains information 
on all drugs of misuse, shows some 
differences from the corresponding “main 
drug” table (Table 7). The most common 
drug of misuse was cannabis, with nearly 
three-fifths (57%) of all individuals 
presenting for treatment reporting misuse of 
cannabis. The second most common drug 
group of misuse was other opiates (28%) 
followed closely by ecstasy (27%); heroin 
(24%); and benzodiazepines (24%).  
 
 
4. Treatment History 
 
4.1 Two-fifths of those presenting to 
treatment in 2001-2 had previously been 
treated for drug misuse. Most users (60%) 
had not been treated before. (Table 10) 
These figures exclude a small number of 
users whose treatment history is unknown.  
 
4.2 There was considerable variation 
between the treatment histories of those 
presenting for different main drugs of 
misuse: whereas approximately three 
quarters (74%) of those having heroin as 
their main drug of misuse had been treated 
before, figures for many other drugs were 
lower: 23% of those presenting with 
cannabis as their man drug had been treated 
before: figures for those presenting with 
ecstasy and solvents as main drug were 21% 
and 9% respectively.  Some of this variation 
is attributable to an age effect, but within 
age bands this pattern is also discernable – 
for example 84% of heroin users aged 20-25 
Figure 6. Average age of first use for different 
main drugs: 2001-2002
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had been treated before compared to 21% of 
cannabis users in the same age band. (Figure 
7)  
 
Figure 7: Percentage of users previously 
treated for selected drugs and age groups
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5.  Injecting and Sharing Behaviour 
 
Injecting Behaviour 
5.1 Data regarding a user’s injecting 
behaviour are collected in two different 
ways. The route of administration for drugs 
of misuse is recorded; and another question 
asks users if they have ever injected any 
drug.  
 
Current Injecting Behaviour 
5.2 For users presenting to treatment and 
for whom the route of administration is 
known, 167 (20%) reported currently 
injecting their main drug. Other main routes 
of administration are swallowing or 
chewing  (oral) – 39%; smoking (32%); and 
sniffing (8%).  
 
5.3 Injecting was mainly limited to 
heroin users – of the 167 injectors, more 
than 9 out of 10 reported injecting heroin. 
Cannabis, by contrast, was usually smoked 
(87% of cannabis users smoked the drug). 
Solvents were usually sniffed. (Table 11) 
 
Lifetime Injecting Behaviour 
5.4 Injecting history is known for 861 
persons presenting for treatment. Table 12 
shows that around one-quarter (26%) of 
these reported ever having injected a drug. 
Males presenting for treatment were almost 
twice as likely to have injected than females 
(30% compared to 16%). 
 
5.5 There was a marked concentration of 
injectors in the Northern HSSB area: three-
fifths (60%) of all lifetime injectors were 
treated in this area. Put another way, 86% of 
people presenting in the Northern HSSB 
area had a history of injecting: the 
corresponding figure for the other three 
Board areas taken together was 13%.  
 
5.6 Information on the age that injectors 
began injecting is available in respect of 204 
injectors (Table 13). The modal age group 
for commencing injecting was 20-25 years, 
with two-fifths (41%) of injectors starting in 
that age range. However nearly a third 
(30%) commenced before age 20, most of 
these in their late teens.  
 
Sharing Equipment 
5.7 The Department of Health, in their 
statistical publications on regional DMDs, 
suggest that reliance on a single question 
about sharing behaviour is likely to produce 
an underestimate of true sharing behaviour. 
The Northern Ireland DMD also uses a 
single question to elicit information about 
sharing behaviour, and thus the results 
quoted in this bulletin should be treated as 
minimum estimates.  
 
5.8 Information about the sharing of 
drug paraphernalia is known for 378 people. 
(Table 14) Of these, just over one-third 
reported sharing equipment. Men (40% of 
whom had shared) were much more likely 
to have shared equipment than women 
(19%).  
 
5.9  Sharing was much more common in 
the Northern Board area (70% reported 
sharing) than in other Board areas (eg 
Eastern Board, 17%). This strongly suggests 
that the equipment being shared was 
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injecting equipment, given the higher rates 
of injecting in the Northern Board area. 
 
6. Viral Testing 
 
6.1 The incidences of HIV, Hepatitis B, 
and Hepatitis C amongst injecting drug 
users are of concern to the individuals 
themselves; their partners and prospective 
partners; and generally for public health 
reasons.  
 
6.2   The DMD records if ever-injected 
individuals presenting for treatment had 
previously  been offered diagnostic tests for 
HIV, Hepatitis B, and Hepatitis C: it does 
not record if individuals took up these offers 
or the results of any tests. Information for 
2001-2002 is available in respect of 213 
persons in relation to HIV; 217 for Hepatitis 
B; and 215 for Hepatitis C.  
 
6.3 Table 15 shows that half of all 
injecting drug users had previously been 
offered an HIV test; 71% a test for Hepatitis 
B; and 68% a test for Hepatitis C. In 
general, the incidence of test offers for 
Hepatitis B and Hepatitis C (but not HIV) 
was higher for those being treated in the 
Northern Board area. 
6.4 These data from the DMD are being 
supplemented from June 2002 on with the 
introduction of an anonymised testing study 
of injecting drug users in contributing 
agencies in Northern Ireland. This study is 
being carried out in conjunction with the 
Public Health Laboratory Service. This 
study should provide robust data on levels 
of infection in the injecting drug-using 
population. (see Annex D) 
7. Other Information 
 
7.1 Some background information on 
users presenting for treatment is given in 
Tables 16-19.  
 
Living Arrangements 
7.2 Two-fifths (40%) of those presenting 
for treatment lived with their parents, and 
one-fifth (20%) lived alone. A similar 
proportion (22%) lived with a partner, and 
one in twenty (5%) were single parents. 
Around 2% of respondents were homeless. 
(Table 16)  
 
Employment Status 
7.3 Around one-sixth (17%) of those 
presenting for treatment were in 
employment at the time that treatment 
commenced. Two-thirds  (67%) were out of 
work, with 13% not having ever been in 
paid employment, and the majority of the 
rest being unemployed for a year or longer. 
13% were students. (Table 17) 
 
Referral Agencies 
7.4 The largest group of those 
presenting for treatment were referred by 
General Practitioners – referrals from GPs 
made up around one-third (34%) of all 
referrals. More than a quarter (27%) were 
self-referred. The remainder came from a 
wide variety of sources, including family 
and friends (10%); and other health and 
social services sources (eg through mental 
health services – 8%; social services – 6%). 
(Table 18) 
 
Legal Status 
7.5 Nearly a third (31% or 283) of 
individuals presenting for treatment had 
some sort of contact with the criminal 
justice system at the time of presenting for 
treatment. The largest group (111) were on 
probation, with a further 100 awaiting trial. 
Some caution needs to be exercised when 
considering these figures as the data do not 
allow those who have no contact with the 
criminal justice system to be distinguished 
from those for whom legal status is not 
known. (Table 19) 
 
Health and Social Services Board data 
7.6 Many of the main tables in Annex A 
contain a breakdown by Health and Social 
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Services Board area. Additional analyses by 
HSSB area are given in Annex B. 
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9. Editorial Notes 
 
9.1 Data were first collected for the 
DMD in Northern Ireland from 1 April 
2000.  The DMD was in a development 
stage in 2000-2001, and data from that year 
are not suitable for publication. This bulletin 
contains the first data from the Northern 
Ireland DMD to be published. Details about 
the Northern Ireland Drug Misuse Database 
are given in Annex C. 
 
9.2 For the purposes of clarity, figures in 
this bulletin are shown in accordance with 
the following publication conventions: 
.  not applicable 
-  zero 
0  less than 0.5%  
 
9.3 Percentages do not always add to 
100 due to rounding. 
 
 
 
 
 
 
 
 
9.4 Any comments or questions 
concerning the data contained in this 
publication, or requests for further 
information, should be addressed to: 
 
Dave Rogers 
DAIRU 
Annex 2 
Castle Buildings 
Stormont 
Belfast BT4 3UD 
telephone: 028 9052 2607 
fax: 028 90 52 3288 
e-mail: dave.rogers@dhsspsni.gov.uk 
 
9.5 Further copies of this publication 
can be obtained from the above address, or 
on-line at 
www.dhsspsni.gov.uk/iau/pubs.html. 
Many other statistical and research reports 
from the Department of Health, Social 
Services and Public Safety’s Information 
and Analysis Unit are available at this web 
address.  
 
The Northern Ireland Statistics and 
Research Agency 
9.6 The Northern Ireland Statistics and 
Research Agency (NISRA) is the principal 
source of official statistical information  
about Northern Ireland. Further information 
is available from the NISRA website at 
www.nisra.gov.uk or via e-mail at 
info.nisra@dfpni.gov.uk.  
 
Future Publications 
9.7 This DMD publication will be 
updated on an annual basis. The next DMD 
Statistical Bulletin will be published on 
Tuesday 14th October 2003. Updates on key 
statistics may be published from time to 
time.  
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Table 1.  Total number of DMD forms received from each Health and Social 
Services Board Area: 2001-2002 
 
       numbers and percentages 
 
HSSB 
Total number of 
forms received (a)
Number of consent 
withheld forms 
received (b)
Number of forms 
analysed (c) 
  
Eastern 493 22 471 
Northern 187 29 158 
Southern 34 - 34 
Western 255 2 253 
   
TOTAL 969 53 916 
  
  
  
Percentages  
  
Eastern 51 42 51 
Northern 19 55 17 
Southern 4 - 4 
Western 26 4 28 
  
TOTAL 100 100 100 
 
 
(a) A DMD form is completed for every new problem drug user who presents at an Agency for 
treatment.  This covers only those problem drug users attending the Agency for the very first time, or 
for those who have not attended the Agency within the previous six months.  They must present with 
a drug related problem 
 
(b) The provision of information to the database is voluntary exercise requiring client consent. Where 
consent is not given a blank form is returned with ‘consent withheld’ written across it, along with the 
designated Agency code. 
 
(c) All data in this statistical bulletin are based on an analysis of DMD forms where consent is given. 
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Table 2.   Gender of individuals presenting for treatment by Health and Social 
Services Board Area: 2001-2002 
 
       numbers and percentages 
 
HSSB Males Females Persons 
   
Eastern 350 121 471 
Northern 126 32 158 
Southern 24 10 34 
Western 181 72 253 
   
TOTAL 681 235 916 
   
   
   
Percentages   
   
Eastern 74 26 100 
Northern 80 20 100 
Southern 71 29 100 
Western 72 28 100 
   
TOTAL 74 26 100 
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Table 3.   Age of individuals presenting for treatment by Health and Social 
Services Board Area: 2001-2002 
 
       numbers and percentages 
 
HSSB 
Under 16 
years 
16-19 
years 
20-25 
years
26-29 
years
30-39 
years
40 years 
and over Persons 
    
Eastern 68 74 91 61 124 53 471 
Northern - 3 66 43 39 7 158 
Southern 1 3 4 6 18 2 34 
Western 15 40 64 40 58 36 253 
    
TOTAL 84 120 225 150 239 98 916 
    
    
    
Percentages    
    
Eastern 14 16 19 13 26 11 100 
Northern - 2 42 27 25 4 100 
Southern 3 9 12 18 53 6 100 
Western 6 16 25 16 23 14 100 
    
TOTAL 9 13 25 16 26 11 100 
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Table 4.   Age and gender of individuals presenting for treatment by Health and 
Social Services Board Area: 2001-2002 
 
       numbers and percentages 
 
Age group Males Females Persons 
  
Under 16 years 65 19 84 
16-19 years 87 33 120 
20-25 years 179 46 225 
26-29 years 117 33 150 
30-39 years 173 66 239 
40 years and over 60 38 98 
  
ALL AGES 681 235 916 
  
  
  
Percentages  
  
Under 16 years 10 8 9 
16-19 years 13 14 13 
20-25 years 26 20 25 
26-29 years 17 14 16 
30-39 years 25 28 26 
40 years and over 9 16 11 
  
ALL AGES 100 100 100 
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Table 5.   Agency type of individuals presenting for treatment in each Health 
and Social Services Board Area: 2001-2002 
 
       numbers and percentages 
 
HSSB Non-statutory Statutory Persons 
  
Eastern 247 224 471 
Northern - 158 158 
Southern 1 33 34 
Western 32 221 253 
  
TOTAL 280 636 916 
  
  
  
Percentages  
  
Eastern 52 48 100 
Northern - 100 100 
Southern 3 97 100 
Western 13 87 100 
  
TOTAL 31 69 100 
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Table 6.   Main drug of misuse of individuals presenting for treatment by 
gender: 2001-2002 
 
       numbers and percentages 
 
Main Drug (a) Male Female Persons 
  
Cannabis  263 48 311 
Ecstasy 64 23 87 
Cocaine 17 4 21 
Crack cocaine 6 - 6 
Heroin 164 32 196 
Methadone 2 - 2 
Other Opiates 55 71 126 
Benzodiazepines 35 20 55 
Barbiturates - - - 
Other hallucinogens - - - 
Amphetamines 2 1 3 
Other stimulants 7 3 10 
Solvents 45 14 59 
Other drugs 21 19 40 
  
TOTAL 681 235 916 
  
  
  
Percentages  
  
Cannabis  39 20 34 
Ecstasy 9 10 9 
Cocaine 2 2 2 
Crack cocaine 1 - 1 
Heroin 24 14 21 
Methadone 0 - 0 
Other Opiates 8 30 14 
Benzodiazepines 5 9 6 
Barbiturates - - - 
Other hallucinogens - - - 
Amphetamines 0 0 0 
Other stimulants 1 1 1 
Solvents 7 6 6 
Other drugs 3 8 4 
  
TOTAL 100 100 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table 7.   Main drug of misuse of individuals presenting for treatment by age: 
2001-2002 
 
       numbers and percentages 
 
Main Drug (a) 
Under 
16 years 
16-19 
years
20-25 
years
26-29 
years
30-39 
years
40 years 
and 
over Persons 
   
Cannabis  43 65 76 40 66 21 311 
Ecstasy 1 25 29 10 20 2 87 
Cocaine - 2 7 3 5 4 21 
Crack cocaine - 2 2 1 1 - 6 
Heroin - 4 69 57 59 7 196 
Methadone - - - - 1 1 2 
Other Opiates - 4 18 22 48 34 126 
Benzodiazepines - 3 10 10 17 15 55 
Barbiturates - - - - - - - 
Other hallucinogens - - - - - - - 
Amphetamines - 2 1 - - - 3 
Other stimulants - 3 1 3 2 1 10 
Solvents 40 9 7 - 3 - 59 
Other drugs - 1 5 4 17 13 40 
   
TOTAL 84 120 225 150 239 98 916 
   
   
   
Percentages   
   
Cannabis  51 54 34 27 28 21 34 
Ecstasy 1 21 13 7 8 2 9 
Cocaine - 2 3 2 2 4 2 
Crack cocaine - 2 1 1 0 - 1 
Heroin - 3 31 38 25 7 21 
Methadone - - - - 0 1 0 
Other Opiates - 3 8 15 20 35 14 
Benzodiazepines - 3 4 7 7 15 6 
Barbiturates - - - - - - - 
Other hallucinogens - - - - - - - 
Amphetamines - 2 0 - - - 0 
Other stimulants - 3 0 2 1 1 1 
Solvents 48 8 3 - 1 - 6 
Other drugs - 1 2 3 7 13 4 
   
TOTAL 100 100 100 100 100 100 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table 8.   Main drug of misuse of individuals presenting for treatment by 
Health and Social Services Board Area: 2001-2002 
 
       numbers and percentages 
 
Main Drug (a) Eastern Northern Southern Western Persons 
   
Cannabis  188 5 12 106 311 
Ecstasy 50 3 3 31 87 
Cocaine 13 - 2 6 21 
Crack cocaine 1 3 - 2 6 
Heroin 47 133 6 10 196 
Methadone 2 - - - 2 
Other Opiates 71 10 8 37 126 
Benzodiazepines 40 1 2 12 55 
Barbiturates - - - - - 
Other hallucinogens - - - - - 
Amphetamines 3 - - - 3 
Other stimulants 3 1 - 6 10 
Solvents 44 - 1 14 59 
Other drugs 9 2 - 29 40 
   
TOTAL 471 158 34 253 916 
   
   
   
Percentages   
   
Cannabis  40 3 35 42 34 
Ecstasy 11 2 9 12 9 
Cocaine 3 - 6 2 2 
Crack cocaine 0 2 - 1 1 
Heroin 10 84 18 4 21 
Methadone 0 - - - 0 
Other Opiates 15 6 24 15 14 
Benzodiazepines 8 1 6 5 6 
Barbiturates - - - - - 
Other hallucinogens - - - - - 
Amphetamines 1 - - - 0 
Other stimulants 1 1 - 2 1 
Solvents 9 - 3 6 6 
Other drugs 2 1 - 11 4 
   
TOTAL 100 100 100 100 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment.   
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Table 9.   All drugs of misuse of individuals presenting for treatment by Health 
and Social Services Board Area: 2001-2002 
 
       numbers and percentages 
 
Main Drug (a) Eastern Northern Southern Western All Boards 
   
Persons 471 158 34 253 916 
   
Cannabis  273 80 19 151 523 
Ecstasy 111 30 17 85 243 
Cocaine 50 19 6 37 112 
Crack cocaine 3 16 - 5 24 
Heroin 54 139 8 20 221 
Methadone 4 1 - - 5 
Other Opiates 104 90 11 48 253 
Benzodiazepines 92 86 7 31 216 
Barbiturates - - - - - 
Other hallucinogens 1 - 1 1 3 
Amphetamines 24 12 5 15 56 
Other stimulants 40 6 1 37 84 
Solvents 58 - 1 17 76 
Other drugs 34 6 5 46 91 
   
   
   
Percentages   
   
Cannabis  58 51 56 60 57 
Ecstasy 24 19 50 34 27 
Cocaine 11 12 18 15 12 
Crack cocaine 1 10 - 2 3 
Heroin 11 88 24 8 24 
Methadone 1 1 - - 1 
Other Opiates 22 57 32 19 28 
Benzodiazepines 20 54 21 12 24 
Barbiturates - - - - - 
Other hallucinogens 0 - 3 0 0 
Amphetamines 5 8 15 6 6 
Other stimulants 8 4 3 15 9 
Solvents 12 - 3 7 8 
Other drugs 7 4 15 18 10 
 
(a) The main drug is the drug which is causing the client the most problems at the time they present 
themselves to the Agency for treatment. A further four subsidiary drugs can be recorded. The figures 
for “all drugs” include all drugs recorded either as the main or a subsidiary drug. These figures add up 
to more than 100%. 
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Table 10.   Treatment history of individuals presenting for treatment by main 
drug of misuse: 2001-2002 
 
       numbers and percentages 
 
Main Drug (a) 
Treated 
before 
Not treated 
before
Treatment history 
unknown TOTAL 
    
Cannabis  71 232 8 311 
Ecstasy 18 69 - 87 
Cocaine 7 14 - 21 
Crack cocaine 3 3 - 6 
Heroin 144 50 2 196 
Methadone 2 - - 2 
Other Opiates 63 55 8 126 
Benzodiazepines 23 32 - 55 
Barbiturates - - - - 
Other hallucinogens - - - - 
Amphetamines 1 2 - 3 
Other stimulants 5 5 - 10 
Solvents 5 53 1 59 
Other drugs 18 22 - 40 
    
TOTAL 360 537 19 916 
    
    
    
Percentages (b)    
    
Cannabis  23 77 .. 100 
Ecstasy 21 79 .. 100 
Cocaine 33 67 .. 100 
Crack cocaine 50 50 .. 100 
Heroin 74 26 .. 100 
Methadone 100 - .. 100 
Other Opiates 53 47 .. 100 
Benzodiazepines 42 58 .. 100 
Barbiturates - - .. 100 
Other hallucinogens - - .. 100 
Amphetamines 33 67 .. 100 
Other stimulants 50 50 .. 100 
Solvents 9 91 .. 100 
Other drugs 45 55 .. 100 
    
TOTAL 40 60 .. 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment.   
 
(b) The percentage of users who have previously been treated has been based on those whose 
treatment history is known and excludes those for whom treatment history was not known.
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Table 11.   Route of administration for main drug of misuse by individuals 
presenting for treatment: 2001-2002 
 
       numbers and percentages 
 
Main Drug (a) Inject Oral Smoke Sniff TOTAL 
   
Cannabis  - 32 229 1 262 
Ecstasy - 81 - - 81 
Cocaine 1 2 4 11 18 
Crack cocaine - 1 3 2 6 
Heroin 152 1 28 - 181 
Methadone 1 1 - - 2 
Other Opiates 4 111 - - 115 
Benzodiazepines - 49 - - 49 
Barbiturates - - - - - 
Other hallucinogens - - - - - 
Amphetamines - 1 - 1 2 
Other stimulants 2 5 - 1 8 
Solvents 1 2 - 52 55 
Other drugs 6 30 - - 36 
   
TOTAL 167 316 264 68 815 
   
   
   
Percentages   
   
Cannabis  - 12 87 0 100 
Ecstasy - 100 - - 100 
Cocaine 6 11 22 61 100 
Crack cocaine - 17 50 33 100 
Heroin 84 1 15 - 100 
Methadone 50 50 - - 100 
Other Opiates 3 97 - - 100 
Benzodiazepines - 100 - - 100 
Barbiturates - - - - - 
Other hallucinogens - - - - - 
Amphetamines - 50 - 50 100 
Other stimulants 25 63 - 13 100 
Solvents 2 4 - 95 100 
Other drugs 17 83 - - 100 
   
TOTAL 20 39 32 8 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment.   
 
(b) This figure excludes 101 DMD forms where the route of administration was not recorded.
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Table 12.   Gender of individuals presenting for treatment who have ever 
injected by Health and Social Services Board Area: 2001-2002 
 
       numbers and percentages 
 
HSSB 
Males 
ever 
injected 
Males with 
known 
injecting 
history
Females 
ever 
injected
Females 
with known 
injecting 
history
Persons 
ever 
injected
Persons 
with 
known 
injecting 
history 
   
Eastern 44 318 9 105 53 423 
Northern 111 123 23 32 134 155 
Southern 4 24 - 10 4 34 
Western 31 177 3 72 34 249 
   
TOTAL 190 642 35 219 225 861 
   
   
   
Percentages (a)   
   
Eastern 14 9 13  
Northern 90 72 86  
Southern 17 - 12  
Western 18 4 14  
   
TOTAL 30 16 26  
 
(a) The percentage of users who have ever injected has been based on those whose injecting status is 
known, i.e. excluding those for whom the injecting status was not known. 
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Table 13.   Age first injected of individuals presenting for treatment who have 
ever injected by Health and Social Services Board Area: 2001-2002 
 
       numbers and percentages 
 
HSSB 
Under 16 
years 
16-19 
years 
20-25 
years
26-29 
years
30-39 
years
40 years 
and over Persons 
    
Eastern - 10 21 8 2 - 41 
Northern 3 38 48 25 12 4 130 
Southern - 1 2 - 1 - 4 
Western 1 9 13 4 2 - 29 
    
TOTAL 4 58 84 37 17 4 204(b) 
    
    
    
Percentages (a)    
    
Eastern - 24 51 20 5 - 100 
Northern 2 29 37 19 9 3 100 
Southern - 25 50 - 25 - 100 
Western 3 31 45 14 7 - 100 
    
TOTAL 2 28 41 18 8 2 100 
 
(a) The percentage of users who have ever injected has been based on those whose injecting status is 
known, i.e. excluding those for whom the status was not known. 
 
(b) This figures excludes 21 individuals who have previously injected but whose age first injected was 
not known. 
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Table 14.   Gender of individuals presenting for treatment who have ever 
shared equipment by Health and Social Services Board Area: 2001-2002 
 
       numbers and percentages 
 
HSSB 
Males 
ever 
shared 
Males with 
known 
sharing 
history
Females 
ever 
shared
Females 
with known 
sharing 
history
Persons 
ever 
shared
Persons 
with 
known 
sharing 
history 
   
Eastern 14 74 4 30 18 104 
Northern 80 108 13 24 93 132 
Southern 2 7 - - 2 7 
Western 17 93 1 42 18 135 
   
TOTAL 113 282 18 96 131 378 
   
   
   
Percentages (a)   
   
Eastern 19 13 17  
Northern 74 54 70  
Southern 29 - 29  
Western 18 2 13  
   
TOTAL 40 19 35  
 
(a) The percentage of users who have ever shared equipment has been based on those whose 
sharing status is known, i.e. excluding those for whom the sharing status was not known.
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Table 15.   Number of injectors who have previously been offered a test for 
HIV, Hepatitis B and Hepatitis C by Health and Social Services Board Area: 
2001-2002 
 
       numbers and percentages 
 
(a) HIV 
 
HSSB 
Offered 
HIV test 
Not Offered
 HIV test Test status unknown TOTAL 
   
Eastern 31 16 6 53 
Northern 59 71 4 134 
Southern 2 2 - 4 
Western 14 18 2 34 
   
TOTAL 106 107 12 225 
   
   
   
Percentages (a)   
   
Eastern 66 34 .. 100 
Northern 45 55 .. 100 
Southern 50 50 .. 100 
Western 44 56 .. 100 
    
TOTAL 50 50 .. 100 
 
(a) The percentage of users who have previously been offered a test for HIV has been based on those 
whose HIV test offer status is known, excluding those for whom the HIV test offer status was not 
known. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 /continued 
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Table 15 (continued) 
 
(b) Hepatitis B 
 
HSSB 
Offered 
Hep B test 
Not Offered
 Hep B test Test status unknown TOTAL 
   
Eastern 31 17 5 53 
Northern 103 29 2 134 
Southern 2 2 - 4 
Western 17 16 1 34 
   
TOTAL 153 64 8 225 
   
   
   
Percentages (a)   
   
Eastern 65 35 .. 100 
Northern 78 22 .. 100 
Southern 50 50 .. 100 
Western 52 48 .. 100 
   
TOTAL 71 29 .. 100 
 
(a) The percentage of users who have previously been offered a test for Hepatitis B has been based 
on those whose Hepatitis B test offer status is known, excluding those for whom the Hepatitis B test 
offer status was not known. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/continued 
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Table 15 (continued) 
 
(c) Hepatitis C 
 
HSSB 
Offered 
Hep C test 
Not Offered
 Hep C test Test status unknown TOTAL 
   
Eastern 30 17 6 53 
Northern 97 34 3 134 
Southern 2 2 - 4 
Western 18 15 1 34 
   
TOTAL 147 68 10 225 
   
   
   
Percentages (a)   
   
Eastern 64 36 .. 100 
Northern 74 26 .. 100 
Southern 50 50 .. 100 
Western 55 45 .. 100 
   
TOTAL 68 32 .. 100 
 
(a) The percentage of users who have ever been offered a test for Hepatitis C has been based on 
those whose Hepatitis C test offer status is known, excluding those for whom the Hepatitis C test offer 
status was not known.
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Table 16.   Living arrangements of individuals presenting for treatment: 2001-
2002 
 
       numbers and percentages 
 
Living arrangements Number % 
  
Alone 175 20 
With spouse/partner  75 8 
With spouse/partner and children 121 14 
With dependent children 41 5 
With parents 356 40 
With friends 36 4 
Residential rehabilitation hostel 27 3 
Roofless 1 0 
Homeless 19 2 
Other 41 5 
  
TOTAL 892 100 
 
 
 
Table 17.   Employment status of individuals presenting for treatment: 2001-
2002 
 
       numbers and percentages 
 
Employment status Number % 
  
In employment 150 17 
Never employed 114 13 
Unemployed-1 year or less 105 12 
Unemployed-1 year or more 375 43 
On government training scheme 10 1 
Student 115 13 
Other 12 1 
  
TOTAL 881 100 
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Table 18.   Referral details of individuals presenting for treatment: 2001-2002 
 
       numbers and percentages 
 
Referral by Number % 
  
GP 307 34 
Psychiatrist/mental health services 76 8 
Social services 55 6 
A+E 6 1 
Community addiction team 32 4 
Non-statutory agency 12 1 
Legal 55 6 
Self 243 27 
Family/friend 87 10 
Workplace 1 0 
Other 35 4 
  
TOTAL 909 100 
 
 
 
Table 19.   Legal status of individuals presenting for treatment: 2001-2002 
 
       numbers and percentages 
 
Legal status Number % 
  
None/missing 624 68 
Deferred sentence 12 1 
On probation 111 12 
Community service 1 0 
Awaiting sentence 59 6 
Trial pending 100 11 
Other 9 1 
  
TOTAL 916 100 
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Table HB1.   Main drug of misuse of individuals presenting for treatment by 
gender: 2001-2002 
 
       numbers and percentages  
 
(a) Eastern Board 
 
Main Drug (a) Male Female Persons 
  
Cannabis  162 26 188 
Ecstasy 34 16 50 
Cocaine 10 3 13 
Crack cocaine 1 - 1 
Heroin 39 8 47 
Methadone 2 - 2 
Other Opiates 32 39 71 
Benzodiazepines 26 14 40 
Barbiturates - - - 
Other hallucinogens - - - 
Amphetamines 2 1 3 
Other stimulants 1 2 3 
Solvents 36 8 44 
Other drugs 5 4 9 
  
TOTAL 350 121 471 
  
  
Percentages  
  
Cannabis  46 21 40 
Ecstasy 10 13 11 
Cocaine 3 2 3 
Crack cocaine 0 - 0 
Heroin 11 7 10 
Methadone 1 - 0 
Other Opiates 9 32 15 
Benzodiazepines 7 12 8 
Barbiturates - - - 
Other hallucinogens - - - 
Amphetamines 1 1 1 
Other stimulants 0 2 1 
Solvents 10 7 9 
Other drugs 1 3 2 
  
TOTAL 100 100 100 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table HB1.   Main drug of misuse (continued) 
(b) Northern Board 
 
Main Drug (a) Male Female Persons 
  
Cannabis  4 1 5 
Ecstasy 2 1 3 
Cocaine - - - 
Crack cocaine 3 - 3 
Heroin 111 22 133 
Methadone - - - 
Other Opiates 3 7 10 
Benzodiazepines 1 - 1 
Barbiturates - - - 
Other hallucinogens - - - 
Amphetamines - - - 
Other stimulants 1 - 1 
Solvents - - - 
Other drugs 1 1 2 
  
TOTAL 126 32 158 
  
  
  
Percentages  
  
Cannabis  3 3 3 
Ecstasy 2 3 2 
Cocaine - - - 
Crack cocaine 2 - 2 
Heroin 88 69 84 
Methadone - - - 
Other Opiates 2 22 6 
Benzodiazepines 1 - 1 
Barbiturates - - - 
Other hallucinogens - - - 
Amphetamines - - - 
Other stimulants 1 - 1 
Solvents - - - 
Other drugs 1 3 1 
  
TOTAL 100 100 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table HB1.   Main drug of misuse (continued) 
 
(c) Southern Board 
 
Main Drug (a) Male Female Persons 
  
Cannabis  9 3 12 
Ecstasy 3 - 3 
Cocaine 2 - 2 
Crack cocaine - - - 
Heroin 6 - 6 
Methadone - - - 
Other Opiates 1 7 8 
Benzodiazepines 2 - 2 
Barbiturates - - - 
Other hallucinogens - - - 
Amphetamines - - - 
Other stimulants - - - 
Solvents 1 - 1 
Other drugs - - - 
  
TOTAL 24 10 34 
  
  
  
Percentages  
  
Cannabis  38 30 35 
Ecstasy 13 - 9 
Cocaine 8 - 6 
Crack cocaine - - - 
Heroin 25 - 18 
Methadone - - - 
Other Opiates 4 70 24 
Benzodiazepines 8 - 6 
Barbiturates - - - 
Other hallucinogens - - - 
Amphetamines - - - 
Other stimulants - - - 
Solvents 4 - 3 
Other drugs - - - 
  
TOTAL 100 100 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table HB1.   Main drug of misuse (continued) 
 
(d) Western Board 
 
Main Drug (a) Male Female Persons 
  
Cannabis  88 18 106 
Ecstasy 25 6 31 
Cocaine 5 1 6 
Crack cocaine 2 - 2 
Heroin 8 2 10 
Methadone - - - 
Other Opiates 19 18 37 
Benzodiazepines 6 6 12 
Barbiturates - - - 
Other hallucinogens - - - 
Amphetamines - - - 
Other stimulants 5 1 6 
Solvents 8 6 14 
Other drugs 15 14 29 
  
TOTAL 181 72 253 
  
  
  
Percentages  
  
Cannabis  49 25 42 
Ecstasy 14 8 12 
Cocaine 3 1 2 
Crack cocaine 1 - 1 
Heroin 4 3 4 
Methadone - - - 
Other Opiates 10 25 15 
Benzodiazepines 3 8 5 
Barbiturates - - - 
Other hallucinogens - - - 
Amphetamines - - - 
Other stimulants 3 1 2 
Solvents 4 8 6 
Other drugs 8 19 11 
  
TOTAL 100 100 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table HB2.   Main drug of misuse of individuals presenting for treatment by 
age: 2001-2002 
 
       numbers and percentages  
 
(a) Eastern Board 
 
Main Drug (a) 
Under 
16 years 
16-19 
years
20-25 
years
26-29 
years
30-39 
years
Over 40 
years Persons 
    
Cannabis  36 41 38 17 42 14 188 
Ecstasy 1 13 16 6 13 1 50 
Cocaine - - 6 1 4 2 13 
Crack cocaine - 1 - - - - 1 
Heroin - 2 10 13 18 4 47 
Methadone - - - - 1 1 2 
Other Opiates - 3 8 15 26 19 71 
Benzodiazepines - 2 7 7 15 9 40 
Barbiturates - - - - - - - 
Other hallucinogens - - - - - - - 
Amphetamines - 2 1 - - - 3 
Other stimulants - 2 - 1 - - 3 
Solvents - 8 3 - 2 - 13 
Other drugs 31 - 2 1 3 3 40 
    
TOTAL 68 74 91 61 124 53 471 
    
    
    
Percentages    
    
Cannabis  53 55 42 28 34 26 40 
Ecstasy 1 18 18 10 10 2 11 
Cocaine - - 7 2 3 4 3 
Crack cocaine - 1 - - - - 0 
Heroin - 3 11 21 15 8 10 
Methadone - - - - 1 2 0 
Other Opiates - 4 9 25 21 36 15 
Benzodiazepines - 3 8 11 12 17 8 
Barbiturates - - - - - - - 
Other hallucinogens - - - - - - - 
Amphetamines - 3 1 - - - 1 
Other stimulants - 3 - 2 - - 1 
Solvents - 11 3 - 2 - 3 
Other drugs 46 - 2 2 2 6 8 
    
TOTAL 100 100 100 100 100 100 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table HB2.   Main drug of misuse by age (continued) 
 
(b) Northern Board 
 
Main Drug (a) 
Under 
16 years 
16-19 
years
20-25 
years
26-29 
years
30-39 
years
Over 40 
years Persons 
    
Cannabis  - - 4 1 - - 5 
Ecstasy - - 2 - - 1 3 
Cocaine - - - - - - - 
Crack cocaine - 1 1 - 1 - 3 
Heroin - 2 55 39 34 3 133 
Methadone - - - - - - - 
Other Opiates - - 4 1 4 1 10 
Benzodiazepines - - - 1 - - 1 
Barbiturates - - - - - - - 
Other hallucinogens - - - - - - - 
Amphetamines - - - - - - - 
Other stimulants - - - 1 - - 1 
Solvents - - - - - - - 
Other drugs - - - - - 2 2 
    
TOTAL - 3 66 43 39 7 158 
    
    
    
Percentages    
    
Cannabis  - - 6 2 - - 3 
Ecstasy - - 3 - - 14 2 
Cocaine - - - - - - - 
Crack cocaine - 33 2 - 3 - 2 
Heroin - 67 83 91 87 43 84 
Methadone - - - - - - - 
Other Opiates - - 6 2 10 14 6 
Benzodiazepines - - - 2 - - 1 
Barbiturates - - - - - - - 
Other hallucinogens - - - - - - - 
Amphetamines - - - - - - - 
Other stimulants - - - 2 - - 1 
Solvents - - - - - - - 
Other drugs - - - - - 29 1 
    
TOTAL - 100 100 100 100 100 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table HB2.   Main drug of misuse by age (continued) 
 
(c) Southern Board 
 
Main Drug (a) 
Under 
16 years 
16-19 
years
20-25 
years
26-29 
years
30-39 
years
Over 40 
years Persons 
    
Cannabis  - 2 1 3 6 - 12 
Ecstasy - - 2 - 1 - 3 
Cocaine - 1 - - - 1 2 
Crack cocaine - - - - - - - 
Heroin - - - 1 5 - 6 
Methadone - - - - - - - 
Other Opiates - - 1 - 6 1 8 
Benzodiazepines - - - 2 - - 2 
Barbiturates - - - - - - - 
Other hallucinogens - - - - - - - 
Amphetamines - - - - - - - 
Other stimulants - - - - - - - 
Solvents 1 - - - - - 1 
Other drugs - - - - - - - 
    
TOTAL 1 3 4 6 18 2 34 
    
    
    
Percentages    
    
Cannabis  - 67 25 50 33 - 35 
Ecstasy - - 50 - 6 - 9 
Cocaine - 33 - - - 50 6 
Crack cocaine - - - - - - - 
Heroin - - - 17 28 - 18 
Methadone - - - - - - - 
Other Opiates - - 25 - 33 50 24 
Benzodiazepines - - - 33 - - 6 
Barbiturates - - - - - - - 
Other hallucinogens - - - - - - - 
Amphetamines - - - - - - - 
Other stimulants - - - - - - - 
Solvents 100 - - - - - 3 
Other drugs - - - - - - - 
    
TOTAL 100 100 100 100 100 100 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table HB2.   Main drug of misuse by age (continued) 
 
(d) Western Board 
 
Main Drug (a) 
Under 
16 years 
16-19 
years
20-25 
years
26-29 
years
30-39 
years
Over 40 
years Persons 
    
Cannabis  7 22 33 19 18 7 106 
Ecstasy - 12 9 4 6 - 31 
Cocaine - 1 1 2 1 1 6 
Crack cocaine - - 1 1 - - 2 
Heroin - - 4 4 2 - 10 
Methadone - - - - - - - 
Other Opiates - 1 5 6 12 13 37 
Benzodiazepines - 1 3 - 2 6 12 
Barbiturates - - - - - - - 
Other hallucinogens - - - - - - - 
Amphetamines - - - - - - - 
Other stimulants - 1 - 1 2 1 5 
Solvents 8 1 4 - 1 - 14 
Other drugs - 1 4 3 14 8 30 
    
TOTAL 15 40 64 40 58 36 253 
    
    
    
Percentages    
    
Cannabis  47 55 52 48 31 19 42 
Ecstasy - 30 14 10 10 - 12 
Cocaine - 3 2 5 2 3 2 
Crack cocaine - - 2 3 - - 1 
Heroin - - 6 10 3 - 4 
Methadone - - - - - - - 
Other Opiates - 3 8 15 21 36 15 
Benzodiazepines - 3 5 - 3 17 5 
Barbiturates - - - - - - - 
Other hallucinogens - - - - - - - 
Amphetamines - - - - - - - 
Other stimulants - 3 - 3 3 3 2 
Solvents 53 3 6 - 2 - 6 
Other drugs - 3 6 8 24 22 12 
    
TOTAL 100 100 100 100 100 100 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table HB3.   Route of administration for main drug of misuse by individuals 
presenting for treatment: 2001-2002 
 
       numbers and percentages  
 
(a) Eastern Board 
 
Main Drug (a) Inject Oral Smoke Sniff TOTAL 
   
Cannabis  - 8 145 1 154 
Ecstasy - 45 - - 45 
Cocaine - 2 2 7 11 
Crack cocaine - - - 1 1 
Heroin 34 - 9 - 43 
Methadone 1 1 - - 2 
Other Opiates - 62 - - 62 
Benzodiazepines - 36 - - 36 
Barbiturates - - - - - 
Other hallucinogens - - - - - 
Amphetamines - 1 - 1 2 
Other stimulants - 1 - 1 2 
Solvents - - - 42 42 
Other drugs 1 6 - - 7 
   
TOTAL 36 162 156 53 407 
   
   
   
Percentages   
   
Cannabis  - 5 95 1 100 
Ecstasy - 100 - - 100 
Cocaine - 18 18 64 100 
Crack cocaine - - - 100 100 
Heroin 79 - 21 - 100 
Methadone 50 50 - - 100 
Other Opiates - 100 - - 100 
Benzodiazepines - 100 - - 100 
Barbiturates - - - - - 
Other hallucinogens - - - - - 
Amphetamines - 50 50 100 
Other stimulants - 50 - 50 100 
Solvents - - - 100 100 
Other drugs 14 86 - - 100 
   
TOTAL 9 40 39 13 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table HB3.   Route of administration (continued) 
 
(b) Northern Board 
 
Main Drug (a) Inject Oral Smoke Sniff TOTAL 
   
Cannabis  - - 4 - 4 
Ecstasy - 3 - - 3 
Cocaine - - - - - 
Crack cocaine - - 3 - 3 
Heroin 109 - 16 - 125 
Methadone - - - - - 
Other Opiates - 10 - - 10 
Benzodiazepines - 1 - - 1 
Barbiturates - - - - - 
Other hallucinogens - - - - - 
Amphetamines - - - - - 
Other stimulants - 1 - - 1 
Solvents - - - - - 
Other drugs 1 - - - 1 
   
TOTAL 110 15 23 - 148 
   
   
   
Percentages   
   
Cannabis  - - 100 - 100 
Ecstasy - 100 - - 100 
Cocaine - - - - - 
Crack cocaine - - 100 - 100 
Heroin 87 - 13 - 100 
Methadone - - - - - 
Other Opiates - 100 - - 100 
Benzodiazepines - 100 - - 100 
Barbiturates - - - - - 
Other hallucinogens - - - - - 
Amphetamines - - - - - 
Other stimulants - 100 - - 100 
Solvents - - - - - 
Other drugs - - - - - 
   
TOTAL 74 10 16 - 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table HB3.   Route of administration (continued) 
 
(c) Southern Board 
 
Main Drug (a) Inject Oral Smoke Sniff TOTAL 
   
Cannabis  - - 12 - 12 
Ecstasy - 3 - - 3 
Cocaine - - 1 1 2 
Crack cocaine - - - - - 
Heroin 3 1 2 - 6 
Methadone - - - - - 
Other Opiates - 7 - - 7 
Benzodiazepines - 2 - - 2 
Barbiturates - - - - - 
Other hallucinogens - - - - - 
Amphetamines - - - - - 
Other stimulants - - - - - 
Solvents - 1 - - 1 
Other drugs - - - - - 
   
TOTAL 3 14 15 1 33 
   
   
   
Percentages   
   
Cannabis  - - 100 - 100 
Ecstasy - 100 - - 100 
Cocaine - - 50 50 100 
Crack cocaine - - - - - 
Heroin 50 17 33 - 100 
Methadone - - - - - 
Other Opiates - 100 - - 100 
Benzodiazepines - 100 - - 100 
Barbiturates - - - - - 
Other hallucinogens - - - - - 
Amphetamines - - - - - 
Other stimulants - - - - - 
Solvents - 100 100 
Other drugs - - - - - 
   
TOTAL 9 42 45 3 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table HB3.   Route of administration (continued) 
 
(d) Western Board 
 
Main Drug (a) Inject Oral Smoke Sniff TOTAL 
   
Cannabis  - 24 68 - 92 
Ecstasy - 30 - - 30 
Cocaine 1 - 1 3 5 
Crack cocaine - 1 - 1 2 
Heroin 6 - 1 - 7 
Methadone - - - - - 
Other Opiates 4 32 - - 36 
Benzodiazepines - 10 - - 10 
Barbiturates - - - - - 
Other hallucinogens - - - - - 
Amphetamines - - - - - 
Other stimulants 2 3 - - 5 
Solvents 1 1 - 10 12 
Other drugs 4 24 - - 28 
   
TOTAL 18 125 70 14 227 
   
   
   
Percentages   
   
Cannabis  - 26 74 - 100 
Ecstasy - 100 - - 100 
Cocaine 20 - 20 60 100 
Crack cocaine - 50 - 50 100 
Heroin 86 - 14 - 100 
Methadone - - - - - 
Other Opiates 11 89 - - 100 
Benzodiazepines - 100 - - 100 
Barbiturates - - - - - 
Other hallucinogens - - - - - 
Amphetamines - - - - - 
Other stimulants 40 60 - - 100 
Solvents 8 8 - 83 100 
Other drugs 14 86 - - 100 
   
TOTAL 8 55 31 6 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment. 
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Table HB4.   Treatment history of individuals presenting for treatment by main 
drug of misuse: 2001-2002 
       numbers and percentages  
(a) Eastern Board 
 
Main Drug (a) 
Treated 
before 
Not treated 
before
Treatment history 
unknown TOTAL 
    
Cannabis  45 136 7 188 
Ecstasy 10 40 - 50 
Cocaine 2 11 - 13 
Crack cocaine 1 - - 1 
Heroin 27 20 - 47 
Methadone 2 - - 2 
Other Opiates 34 29 8 71 
Benzodiazepines 14 26 - 40 
Barbiturates - - - - 
Other hallucinogens - - - - 
Amphetamines 1 2 - 3 
Other stimulants 1 2 - 3 
Solvents 4 40 - 44 
Other drugs 4 5 - 9 
   0 
TOTAL 145 311 15 471 
    
Percentages (b)    
    
Cannabis  25 75 .. 100 
Ecstasy 20 80 .. 100 
Cocaine 15 85 .. 100 
Crack cocaine 100 - .. 100 
Heroin 57 43 .. 100 
Methadone - - .. 100 
Other Opiates 54 46 .. 100 
Benzodiazepines 35 65 .. 100 
Barbiturates - - .. 100 
Other hallucinogens - - .. 100 
Amphetamines 33 67 .. 100 
Other stimulants 33 67 .. 100 
Solvents 9 91 .. 100 
Other drugs 44 56 .. 100 
    
TOTAL 32 68 .. 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment.  
(b) The percentage of users who have previously been treated has been based on those whose 
treatment history is known, i.e. excluding those for whom the treatment history was not known. 
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Table HB4.   Treatment history (continued) 
 
(b) Northern Board 
 
Main Drug (a) 
Treated 
before 
Not treated 
before
Treatment history 
unknown TOTAL 
    
Cannabis  1 4 - 5 
Ecstasy 1 2 - 3 
Cocaine - - - - 
Crack cocaine 1 2 - 3 
Heroin 108 23 2 133 
Methadone - - - - 
Other Opiates 5 5 - 10 
Benzodiazepines 1 - - 1 
Barbiturates - - - - 
Other hallucinogens - - - - 
Amphetamines - - - - 
Other stimulants - 1 - 1 
Solvents - - - - 
Other drugs 2 - - 2 
    
TOTAL 119 37 2 158 
    
    
    
Percentages (b)    
    
Cannabis  20 80 .. 100 
Ecstasy 33 67 .. 100 
Cocaine - - .. 100 
Crack cocaine 33 67 .. 100 
Heroin 82 18 .. 100 
Methadone - - .. 100 
Other Opiates 50 50 .. 100 
Benzodiazepines 100 - .. 100 
Barbiturates - - .. 100 
Other hallucinogens - - .. 100 
Amphetamines - - .. 100 
Other stimulants - 100 .. 100 
Solvents - - .. 100 
Other drugs 100 - .. 100 
    
TOTAL 76 24 .. 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment.  
 
(b) The percentage of users who have previously been treated has been based on those whose 
treatment history is known, i.e. excluding those for whom the treatment history was not known. 
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Table HB4.   Treatment history (continued) 
 
(c) Southern Board 
 
Main Drug (a) 
Treated 
before 
Not treated 
before
Treatment history 
unknown TOTAL 
    
Cannabis  5 7 - 12 
Ecstasy 1 2 - 3 
Cocaine 1 1 - 2 
Crack cocaine - - - - 
Heroin 4 2 - 6 
Methadone - - - - 
Other Opiates 4 4 - 8 
Benzodiazepines 1 1 - 2 
Barbiturates - - - - 
Other hallucinogens - - - - 
Amphetamines - - - - 
Other stimulants - - - - 
Solvents - - - - 
Other drugs - - - - 
    
TOTAL 16 17 1 34 
    
    
    
Percentages (b)    
    
Cannabis  42 58 .. 100 
Ecstasy 33 67 .. 100 
Cocaine 50 50 .. 100 
Crack cocaine - - .. 100 
Heroin 67 33 .. 100 
Methadone - - .. 100 
Other Opiates 50 50 .. 100 
Benzodiazepines 50 50 .. 100 
Barbiturates - - .. 100 
Other hallucinogens - - .. 100 
Amphetamines - - .. 100 
Other stimulants - - .. 100 
Solvents - - .. 100 
Other drugs - - .. 100 
    
TOTAL 48 52 .. 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment.   
 
(b) The percentage of users who have previously been treated has been based on those whose 
treatment history is known, i.e. excluding those for whom the treatment history was not known. 
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Table HB4.   Treatment history (continued) 
 
(d) Western Board 
 
Main Drug (a) 
Treated 
before 
Not treated 
before
Treatment history 
unknown TOTAL 
    
Cannabis  20 85 1 106 
Ecstasy 6 25 - 31 
Cocaine 4 2 - 6 
Crack cocaine 1 1 - 2 
Heroin 5 5 - 10 
Methadone - - - - 
Other Opiates 20 17 - 37 
Benzodiazepines 7 5 - 12 
Barbiturates - - - - 
Other hallucinogens - - - - 
Amphetamines - - - - 
Other stimulants 4 2 - 6 
Solvents 1 13 - 14 
Other drugs 12 17 - 29 
    
TOTAL 80 172 1 253 
    
    
    
Percentages (b)    
    
Cannabis  19 81 .. 100 
Ecstasy 19 81 .. 100 
Cocaine 67 33 .. 100 
Crack cocaine 50 50 .. 100 
Heroin 50 50 .. 100 
Methadone - - .. 100 
Other Opiates 54 46 .. 100 
Benzodiazepines 58 42 .. 100 
Barbiturates - - .. 100 
Other hallucinogens - - .. 100 
Amphetamines - - .. 100 
Other stimulants 67 33 .. 100 
Solvents 7 93 .. 100 
Other drugs 41 59 .. 100 
    
TOTAL 32 68 .. 100 
 
(a) The main drug of misuse is the drug which is causing the client the most problems at the time they 
present themselves to the Agency for treatment.   
 
(b) The percentage of users who have previously been treated has been based on those whose 
treatment history is known, i.e. excluding those for whom the treatment history was not known. 
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ANNEX C  –  THE NORTHERN IRELAND DRUG MISUSE DATABASE 
 
 
In 1995, the Northern Ireland Drugs Policy Statement highlighted the need for a centralised 
database on drug misuse in Northern Ireland. The then Department of Health and Social 
Services (DHSS) was tasked with taking forward a feasibility study that would consider the 
experience elsewhere (databases already existed in Scotland, Wales and regionally in 
England), data availability and data quality in Northern Ireland and consider issues of 
confidentiality. The consultants employed to carry out the study reported that the majority of 
agencies were supportive of the idea of a drug misuse database and identified twelve agencies 
(six statutory and six non-statutory) as potential providers. 
 
In response to the report DHSS Health established a project group to examine the issues 
involved in the establishment of a drug misuse database, and to make recommendations to the 
Central Co-ordinating Group for Action Against Drugs (CCGAAD) on the best way to carry 
forward the establishment of the database. In April 1999, having considered a report from the 
group, CCGAAD agreed that a database should be created and approved the establishment of 
a project management group to oversee implementation. More specifically, the role of the 
project management group was to design a suitable data collection form and detailed 
guidance notes, and to ensure that adequate training was provided to contributors to the 
database.  
 
In August 1999, a new Drug Strategy for Northern Ireland was launched. It placed a clear 
emphasis on the need for good information to support drug policy and practice and 
recommended that a new programme of information and research should be developed. The 
Drug Strategy also identified a drug misuse database as one approach to collecting 
information. Responsibility for developing the Drug Information and Research Strategy, 
including the Northern Ireland Drug Misuse Database, was assumed by the Drug Information 
and Research Unit (DIRU). This unit was established within the Department of Health, Social 
Services and Public Safety in April 2000 after the transfer of policy responsibility for drug-
related work from the Northern Ireland Office. 
   
The Drug and Alcohol Information and Research Unit (DAIRU) undertake day to day work 
relating to the implementation, management and development of the database, under the 
guidance of the project management group, which is chaired by DAIRU. This new unit 
replaced DIRU and reflects the model for the joint implementation of the Drug and Alcohol 
Strategies as approved by the Executive in May 2001. 
 
The Drug Misuse Database Project Management Group is comprised of representatives of all 
agencies that contribute to the database, the Drug and Alcohol Strategy Team within 
DHSSPS and DAIRU.  
 
The Northern Ireland Drug Misuse Database (NI DMD) has been developed along the lines 
of the regional databases in England. The NI DMD manager is a member of the National 
Forum for Drug Data. This group includes the database managers from Scotland and Wales, 
regional database managers from England and representatives from the Home Office and the 
Department of Health. Following a strategic review of the structure and operation of the 
regional databases in England and Wales, the National Drugs Treatment Monitoring System 
was introduced in April 2001. The new system collects information on clients entering 
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treatment; in addition, further information is collected on each client at the end of each 
financial year including whether or not they are still in treatment.  
 
The aim of the NI DMD is to enhance knowledge and understanding of the drug problem, to 
help inform decision-making and to improve the suitability and range of services available. It 
offers a profile of the misuse of drugs, based on anonymous information about new problem 
drug users presenting for treatment at a broad range of services. The provision of this 
information to the database is a voluntary exercise requiring an individual’s consent. Where 
consent is withheld, the individual is asked to allow two pieces of information, age and sex, 
to be recorded on the form. 
 
Data collection for the Northern Ireland Drug Misuse Database commenced on 1 April 2000. 
Services contributing to the database consist mainly of specialist drug services both statutory 
and non-statutory. Initially, ten agencies (six statutory and four non-statutory) agreed to 
contribute to the database. At the end of March 2002 there were thirteen contributors (at 
twenty-three treatment sites) to the database. Work will continue to enhance existing 
coverage and extend the coverage of the database in the future to more treatment agencies.  
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ANNEX D  –  RESEARCH PROGRAMME 
 
A substantial programme of research has been agreed by the Information and Research 
Working Group (IRWG), which was established to establish and meet the research and 
information needs of the joint implementation of the Drug Strategy and the Strategy for 
Reducing Alcohol Related Harm (see paragraph 1.4). This work, which is being progressed 
by IRWG and DAIRU, includes the following recent and current projects: 
 
Recently Published Research 
 
Heroin Use in Northern Ireland: A qualitative Study into Heroin Users’ Lifestyles, 
Experiences and Risk Behaviours. Karen McElrath. 2001.  
This study examined patterns of drug taking; health issues;  risk behaviours associated with 
injection practices;  and experience of drug treatment practices using qualitative methods in a 
sample of 43 current and former heroin users in Northern Ireland.  
 
Prevalence of Problem Heroin Use in Northern Ireland. Karen McElrath. March 2002. 
This research project made estimates of the prevalence of problem heroin use in Northern 
Ireland in the period November 2000 – October 2001 using a number of different 
methodologies. The central estimate of problem heroin users was in the range 695-1250.  
 
Drug and Alcohol Use Among Young People in Northern Ireland – A Secondary Analysis 
of Drug and Alcohol Use Surveys. Bob Miller and Lizanne Dowds. October 2002. 
This reports the findings of detailed analyses of the drug and alcohol modules of two surveys 
carried out in 2000: the Young Persons Behaviour and Attitudes Survey, a school-based 
survey covering 11-16 year olds; and the NISRA Omnibus Survey, a household survey with 
16-25 year olds being the focus of analysis.  
 
These reports can be obtained from the address on page 9 of this bulletin or on-line at 
www.dhsspsni.gov.uk/iau/pubs.html  
 
 
 
Ongoing Projects 
 
IRWG has a number of projects currently being developed. Projects currently under way are: 
 
All-Ireland Drug Prevalence Survey. A household population survey to estimate the 
prevalence of illicit drug use among 15-64 year-olds in Northern Ireland, the Republic of 
Ireland, and on an all-Ireland basis. The survey is being conducted by MORI/MRC and will 
be completed by June 2003. 
 
Anonymised Salivary Testing Survey Among Injecting Drug Users.  – This Survey 
commenced on 1 June 2002 . The aim of the survey is to monitor trends in HIV and Hepatitis 
B and C infection in injecting drug users. Results from the survey are produced by the Public 
Health Laboratory Service, first results for Northern Ireland will be available by June 2003. 
 
Register of Research on Drugs and Alcohol in Northern Ireland. To be produced by 
DAIRU for publication in March 2003 
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Research into young vulnerable groups.    The first stage of this research will examine the 
profile of young people generally at risk of drug and alcohol misuse, especially examining 
young vulnerable people such as those excluded from school, those in contact with the 
criminal justice system etc. It will also and assess the suitability of service provision for 
young people presenting for service. This research is scheduled for completion in June 2003. 
Further research will focus on the needs of young vulnerable groups.  
 
 
 
 
 
 
   
 
